Evidence map›Paper›PMID 41711410›Full record

ArticleMicrobiologyOpen2026

Green and Ecofriendly Mycosynthesis of Nanocomposite Based on Zinc and Magnesium Oxide Nanoparticles Using Endophytic Sarocladium kiliense: Characterization, Anticancer Activity, Antimicrobial and Antibiofilm Activities.

Samy Selim, Fathy M Elkady, Ebrahim Saied, Amr H Hashem, Amer M Abdelaziz, Mohammed S Abdulrahman, Faisal Alsenani, Omar Awad Alsaidan, Sami I Alzarea, Yousef Alhaj Hamoud and 2 more

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Samy SelimDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.ORCID 0000-0003-4025-8586
Fathy M ElkadyMicrobiology and Immunology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
Ebrahim SaiedBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.ORCID 0000-0002-5622-7912
Amr H HashemBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.ORCID 0000-0002-0024-3606
Amer M AbdelazizBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.ORCID 0000-0003-2410-5168
Mohammed S AbdulrahmanMicrobiology and Immunology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
Faisal AlsenaniDepartment of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0000-0002-7267-9636
Omar Awad AlsaidanDepartment of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.ORCID 0000-0002-2848-2932
Sami I AlzareaDepartment of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.ORCID 0000-0003-4007-4023
Yousef Alhaj HamoudCollege of Hydrology and Water Resources, Hohai University, Nanjing, China.ORCID 0000-0003-0945-9224
Hiba ShaghalehSchool of Energy and Environment, Southeast University, Nanjing, China.
Mohammed AufyDepartment of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.ORCID 0000-0002-6693-4530

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

Fungal species are increasingly recognized as efficient bio-factories for the biosynthesis of nanoparticles with distinctive functionalities. In this study, zinc oxide-magnesium oxide nanocomposite (ZnO-MgO NCs) were biologically created employing the Sarocladium kiliense PV248633.1 fungal strain. Ultraviolet-visible spectroscopy confirmed nanoparticle formation through characteristic absorption peaks, while Fourier-transform infrared spectroscopy identified functional groups associated with metal-oxygen bonds. Also, the nanoparticle size and surface characteristics Transmission electron microscopy and dynamic light scattering analyzes revealed an average particle size of 35 nm. Biological assessments demonstrate potent antitumor activity (IC₅₀ = 78.1 µg/mL) against MCF-7 breast cancer cells, alongside minimal cytotoxicity against normal WI-38 cells (IC₅₀ = 218.7 µg/mL), indicating selective toxicity. Antibacterial evaluations showed particularly high efficacy against Acinetobacter baumannii and Pseudomonas aeruginosa occasionally surpassing the performance of cefepime. Dose-dependent antimicrobial activity was confirmed through well diffusion and broth microdilution techniques, with minimum inhibitory concentrations highlighting strong bactericidal potential. Biofilm inhibition assays revealed strain-specific responses, with A. baumannii being the most susceptible. Furthermore, the synergistic combination of the biosynthesized nanocomposite with cefepime enhanced antibacterial outcomes against selected isolates, suggesting potential for addressing drug resistance. Overall, the mycogenic ZnO-MgO NCs synthesized from S. kiliense exhibited substantial anticancer, antibacterial, and antibiofilm properties, locating this nanocomposite as a promising candidate for biomedical purposes.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsAntineoplastic AgentsBiofilmsEndophytesMagnesium OxideNanocompositesZinc OxideAcinetobacter baumanniiHumansMCF-7 CellsMicrobial Sensitivity TestsMicroscopy, Electron, TransmissionNanoparticlesPseudomonas aeruginosaSpectroscopy, Fourier Transform InfraredAnti-Bacterial AgentsAnti-Infective AgentsAntineoplastic AgentsMagnesium OxideZinc OxideanticancerbiofilmmycosynthesisSarocladium kilienseZnO‐MgO NCs

Identifiers

PMID41711410
PMCPMC12918420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.